Filed: 8/14/2026ACC: 0001193125-26-350681
📋 What this filing means
OMEGA FUND MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 10 equity positions with a total reported market value of $185.69M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
10
Positions
$185.69M
Total AUM (reported)
17.95M
Total Shares
Allocation by class
COMMON STOCK$139.79M75.3%
COMMON STOCK CLASS A$45.90M24.7%
Portfolio Concentration
Top 3$126.00M67.9%
4–10$59.68M32.1%
Top 3 weight
67.9%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 17.95M
Sole
Full voting authority
17.95M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole10
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings10
Rows:
Bicara Therapeutics Inc.
SOLEShares1.82M
TypeSH
Market value$54.10M
29.14%
Sole
1.82M
Shared
0.00
None
0.00
Nuvation Bio Inc.
SOLEShares8.08M
TypeSH
Market value$45.90M
24.72%
Sole
8.08M
Shared
0.00
None
0.00
Kestra Med Technologies Ltd
SOLEShares1.02M
TypeSH
Market value$26.00M
14.00%
Sole
1.02M
Shared
0.00
None
0.00
BridgeBio Oncology Therapeutics Inc.
SOLEShares3.29M
TypeSH
Market value$25.07M
13.50%
Sole
3.29M
Shared
0.00
None
0.00
Beta Bionics Inc.
SOLEShares1.32M
TypeSH
Market value$20.62M
11.11%
Sole
1.32M
Shared
0.00
None
0.00
Alumis Inc.
SOLEShares241.25K
TypeSH
Market value$6.79M
3.66%
Sole
241.25K
Shared
0.00
None
0.00
Sana Biotechnology, Inc.
SOLEShares843.75K
TypeSH
Market value$2.94M
1.59%
Sole
843.75K
Shared
0.00
None
0.00
ImageneBio, Inc.
SOLEShares455.36K
TypeSH
Market value$2.69M
1.45%
Sole
455.36K
Shared
0.00
None
0.00
enGene Holdings Inc.
SOLEShares876.36K
TypeSH
Market value$1.52M
0.82%
Sole
876.36K
Shared
0.00
None
0.00
Odyssey Therapeutics Inc.
SOLEShares2.89K
TypeSH
Market value$54.1K
0.03%
Sole
2.89K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Bicara Therapeutics Inc.SOLE | Common Stock | 1.82M | SH | $54.10M 29.14% | 1.82M | 0.00 | 0.00 |
Nuvation Bio Inc.SOLE | Common Stock Class A | 8.08M | SH | $45.90M 24.72% | 8.08M | 0.00 | 0.00 |
Kestra Med Technologies LtdSOLE | Common Stock | 1.02M | SH | $26.00M 14.00% | 1.02M | 0.00 | 0.00 |
BridgeBio Oncology Therapeutics Inc.SOLE | Common Stock | 3.29M | SH | $25.07M 13.50% | 3.29M | 0.00 | 0.00 |
Beta Bionics Inc.SOLE | Common Stock | 1.32M | SH | $20.62M 11.11% | 1.32M | 0.00 | 0.00 |
Alumis Inc.SOLE | Common Stock | 241.25K | SH | $6.79M 3.66% | 241.25K | 0.00 | 0.00 |
Sana Biotechnology, Inc.SOLE | Common Stock | 843.75K | SH | $2.94M 1.59% | 843.75K | 0.00 | 0.00 |
ImageneBio, Inc.SOLE | Common Stock | 455.36K | SH | $2.69M 1.45% | 455.36K | 0.00 | 0.00 |
enGene Holdings Inc.SOLE | Common Stock | 876.36K | SH | $1.52M 0.82% | 876.36K | 0.00 | 0.00 |
Odyssey Therapeutics Inc.SOLE | Common Stock | 2.89K | SH | $54.1K 0.03% | 2.89K | 0.00 | 0.00 |